Innoviva (INVA) Net Margin Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 24,295.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,295.00 |
| Dec 31, 2025 | -42,065.00 |
| Sep 30, 2025 | 8,206.00 |
| Jun 30, 2025 | 9,823.00 |
| Mar 31, 2025 | -383,352.00 |
| Dec 31, 2024 | -42,286.00 |
| Sep 30, 2024 | -12,063.00 |
| Jun 30, 2024 | -16,533.00 |
| Mar 31, 2024 | -59,907.00 |
| Dec 31, 2023 | 55,219.00 |
| Sep 30, 2023 | -2.03 Mn |
| Jun 30, 2023 | 8,075.00 |
| Mar 31, 2023 | 310,389.00 |
| Dec 31, 2022 | -37,116.00 |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | -756,554.00 |
| Mar 31, 2022 | -755,342.00 |
| Dec 31, 2021 | -1.13 Mn |
| Sep 30, 2021 | 4,221.00 |
| Jun 30, 2021 | 751,807.00 |
| Mar 31, 2021 | 874,638.00 |
| Dec 31, 2020 | 1.06 Mn |
| Sep 30, 2020 | -2,873.00 |
| Jun 30, 2020 | 3,847.00 |
| Mar 31, 2020 | 2,194.00 |
| Dec 31, 2019 | -26,980.00 |
| Sep 30, 2019 | -1,580.00 |
| Jun 30, 2019 | -2,256.00 |
| Mar 31, 2019 | 476.00 |
| Dec 31, 2018 | 24,630.00 |
| Sep 30, 2018 | 2,748.00 |
| Jun 30, 2018 | 2,141.00 |
| Mar 31, 2018 | 1,487.00 |
| Dec 31, 2017 | 2,463.00 |
| Sep 30, 2017 | 373.00 |
| Jun 30, 2017 | 1,506.00 |
| Mar 31, 2017 | 2,326.00 |
| Dec 31, 2016 | 4,051.00 |
| Sep 30, 2016 | 7,893.00 |
| Jun 30, 2016 | 11,825.00 |
| Mar 31, 2016 | 17,303.00 |
| Dec 31, 2015 | 23,760.00 |
| Sep 30, 2015 | 209,543.00 |
| Jun 30, 2015 | 673,227.00 |
| Mar 31, 2015 | 852,519.00 |
| Dec 31, 2014 | 317,085.00 |
| Sep 30, 2014 | 919,246.00 |
| Jun 30, 2014 | -404,997.00 |
| Mar 31, 2014 | -585,385.00 |
| Dec 31, 2013 | -341,480.00 |
| Sep 30, 2013 | -889,567.00 |
| Jun 30, 2013 | 434,192.00 |
| Mar 31, 2013 | -289,327.00 |
| Dec 31, 2012 | 71,536.00 |
| Sep 30, 2012 | -194,979.00 |
| Jun 30, 2012 | -670,551.00 |
| Mar 31, 2012 | 42,528.00 |